Manama, Dr. Ahmed Mohammed Al Ansari, Chief Executive of the National Health Regulatory Authority (NHRA), and Dr. Hisham Saad Al Jadhey, CEO of Saudi Food and Drug Authority (SFDA), signed a Memorandum of Understanding (MoU) to enhance collaboration on the approval of pharmaceuticals and medical devices between Bahrain and Saudi Arabia. The signing was attended by Lieutenant General Dr. Shaikh Mohamed bin Abdullah Al Khalifa, Chairman of the Supreme Council of Health (SCH). Dr. Al Ansari affirmed that this agreement strengthens cooperation between the two authorities, enabling Bahrain to recognise and approve pharmaceutical products and medical devices already authorised by Saudi Arabia's SFDA. He added that the MoU will allow for smoother regulatory processes by aligning standards for pharmaceuticals and medical devices approved by the SFDA, supporting the health sector in both countries. The NHRA and SFDA have signed an agreement in 2019. Source: Bahrain News Agency
PLNT FINAL DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Planet Fitness, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 14 Deadline in Securities Class Action – PLNT
September 11, 2026
NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) —WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Planet Fitness, Inc. (NYSE: PLNT) between November 6, 2025 and May 6, 2026, inclusive (the “Class Period”), of the important September 14, 2026 lead plaintiff deadline. SO WHAT: If you purchased Planet Fitness common stock during […]